Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Cannabis Use and its Association with Psychological Disorders
1 x
$
30.00
View Cart
Checkout
Home
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
“Cannabis Use and its Association with Psychological Disorders” has been added to your cart.
View cart
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-40-3-sheehan
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
aminobutyric-acid-gaba
,
anxiety
,
b-ashok-raj
,
david-v-sheehan
,
juris-janavs
,
kathy-harnett-sheehan
,
mba
,
md
,
panic-disorder
,
phd
,
selective-gaba-reuptake-inhibitor
,
tiagabine
Description
Description
David V. Sheehan, MD
Link
NEGATIVE AND FAILED CLINICAL TRIAL REPORTS
An Open-Label Study of Tiagabine in
Panic Disorder
David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD, and Juris Janavs, MD
Related products
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
Michael S. Clark, MD, PhD: The 5-HT1B Receptor: Behavioral Implications
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Paul A. Cannistraro, MD: Neural Circuitry of Anxiety: Evidence from Structural and Functional Neuroimaging Studies
$
30.00
Add to cart
Details
Page load link
Go to Top
